Global Rapid Medical Diagnostic Kits Market to Reach $18.9 Billion by 2030
The global market for Rapid Medical Diagnostic Kits estimated at US$14.3 Billion in the year 2022, is projected to reach a revised size of US$18.9 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2022-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is projected to record 3.9% CAGR and reach US$10.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Professional Kits segment is readjusted to a revised 3.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 5.9% CAGR
The Rapid Medical Diagnostic Kits market in the U.S. is estimated at US$3.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.Select Competitors (Total 27 Featured) -
- Abbott Laboratories
- Alfa Scientific Designs, Inc.
- Arkray USA, Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Biomerica, Inc.
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Diagnostic Automation / Cortez Diagnostics, Inc.
- EKF Diagnostics Holdings PLC
- Enzo Life Sciences, Inc.
- F. Hoffmann-La Roche AG
- Idexx Laboratories, Inc.
- InBios International
- Jant Pharmacal Corporation
- Labsystems Diagnostics Oy
- LifeScan, Inc.
- Princeton BioMeditech Corporation
- Quidel Corporation
- Rapid Diagnostics Pvt., Ltd.
- Roche Diagnostics
- Runhe Biomedical Technology (Shantou) Co., Ltd.
- SA Scientific
- Sekisui Diagnostics LLC
- Shanghai Kehua Bio-engineering Co., Ltd.
- Siemens Healthineers
- TaiDoc Technology Corporation
- Thermo Fisher Scientific, Inc.
- Zoetis, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Alfa Scientific Designs, Inc.
- Arkray USA, Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Biomerica, Inc.
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Diagnostic Automation / Cortez Diagnostics, Inc.
- EKF Diagnostics Holdings PLC
- Enzo Life Sciences, Inc.
- F. Hoffmann-La Roche AG
- Idexx Laboratories, Inc.
- InBios International
- Jant Pharmacal Corporation
- Labsystems Diagnostics Oy
- LifeScan, Inc.
- Princeton BioMeditech Corporation
- Quidel Corporation
- Rapid Diagnostics Pvt., Ltd.
- Roche Diagnostics
- Runhe Biomedical Technology (Shantou) Co., Ltd.
- SA Scientific
- Sekisui Diagnostics LLC
- Shanghai Kehua Bio-engineering Co., Ltd.
- Siemens Healthineers
- TaiDoc Technology Corporation
- Thermo Fisher Scientific, Inc.
- Zoetis, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 166 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 14.3 Billion |
| Forecasted Market Value ( USD | $ 18.9 Billion |
| Compound Annual Growth Rate | 3.5% |
| Regions Covered | Global |
